Free Trial
NASDAQ:MGRX

Mangoceuticals (MGRX) Stock Price, News & Analysis

Mangoceuticals logo
$1.54 +0.03 (+1.64%)
Closing price 07/3/2025 03:28 PM Eastern
Extended Trading
$1.54 0.00 (0.00%)
As of 07/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Mangoceuticals Stock (NASDAQ:MGRX)

Key Stats

Today's Range
$1.49
$1.58
50-Day Range
$1.38
$2.42
52-Week Range
$1.32
$7.66
Volume
72,419 shs
Average Volume
219,285 shs
Market Capitalization
$7.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mangoceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
18th Percentile Overall Score

MGRX MarketRank™: 

Mangoceuticals scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Mangoceuticals.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mangoceuticals is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mangoceuticals is -0.33, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Mangoceuticals has a P/B Ratio of 0.36. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Mangoceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    2.26% of the float of Mangoceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Mangoceuticals has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mangoceuticals has recently decreased by 53.15%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Mangoceuticals does not currently pay a dividend.

  • Dividend Growth

    Mangoceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.26% of the float of Mangoceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Mangoceuticals has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mangoceuticals has recently decreased by 53.15%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Mangoceuticals this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Mangoceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    16.00% of the stock of Mangoceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    56.72% of the stock of Mangoceuticals is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Mangoceuticals' insider trading history.
Receive MGRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mangoceuticals and its competitors with MarketBeat's FREE daily newsletter.

MGRX Stock News Headlines

Mangoceuticals President Tony Isaac Resigns
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.
See More Headlines

MGRX Stock Analysis - Frequently Asked Questions

Mangoceuticals' stock was trading at $2.42 at the start of the year. Since then, MGRX shares have decreased by 36.2% and is now trading at $1.5450.

Mangoceuticals, Inc. (NASDAQ:MGRX) announced its quarterly earnings data on Thursday, May, 15th. The company reported ($1.29) earnings per share (EPS) for the quarter. The business earned $0.11 million during the quarter. Mangoceuticals had a negative trailing twelve-month return on equity of 72.81% and a negative net margin of 2,191.76%.

Mangoceuticals shares reverse split before market open on Wednesday, October 16th 2024.The 1-15 reverse split was announced on Wednesday, October 16th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, October 16th 2024. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Mangoceuticals (MGRX) raised $5 million in an initial public offering on Tuesday, March 21st 2023. The company issued 1,300,000 shares at a price of $4.00 per share. Boustead Securities served as the underwriter for the IPO.

Shares of MGRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mangoceuticals investors own include Sangamo Therapeutics (SGMO), Meta Platforms (META), NVIDIA (NVDA), MSP Recovery (LIFW), Advanced Micro Devices (AMD) and Charge Enterprises (CRGE).

Company Calendar

Last Earnings
5/15/2025
Today
7/04/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Healthcare
Current Symbol
NASDAQ:MGRX
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.71 million
Net Margins
-2,191.76%
Pretax Margin
-2,191.76%

Debt

Sales & Book Value

Annual Sales
$511.08 thousand
Price / Cash Flow
N/A
Book Value
$4.30 per share
Price / Book
0.36

Miscellaneous

Free Float
4,342,000
Market Cap
$7.99 million
Optionable
Not Optionable
Beta
2.40
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:MGRX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners